Peroxisome Biogenesis Disorders

Annual Review of Genomics and Human Genetics

Volumn 4, Issue , 2003, Pages 165-211

  Weller, Sabine ^a   Gould, Stephen J ^a   Valle, David ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Peroxins; PEX genes; Protein import; Zellweger syndrome

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; AUTOSOMAL RECESSIVE DISORDER; BIOGENESIS; DEVELOPMENTAL DISORDER; DISORDERS OF PEROXISOMAL FUNCTIONS; GENETIC HETEROGENEITY; GENOTYPE PHENOTYPE CORRELATION; HOMEOSTASIS; METABOLIC DISORDER; MOUSE; NONHUMAN; PATHOPHYSIOLOGY; PEROXISOME; PEROXISOME BIOGENESIS DISORDER; PHENOTYPE; REVIEW;

ANIMALS; DISEASE MODELS, ANIMAL; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MICE; PEROXISOMAL DISORDERS; PHENOTYPE; PROGNOSIS;

ANIMALIA;

EID: 0242524498     PISSN: 15278204     EISSN: None     Source Type: Book Series    
DOI: 10.1146/annurev.genom.4.070802.110424     Document Type: Review

References (276)

1. Agamanolis DP, Novak RW. 1995. Rhizomelic chondrodysplasia punctata: Report of a case with review of the literature and correlation with other peroxisomal disorders. Pediatr. Pathol. Lab. Med. 15: 503-13
2. Almashanu S, Valle D. 2003. Peroxisomal ABC transporters. In ABC Proteins: From Bacteria to Man, ed. IB Holland, K Kuchler, CF Higgins, S Cole, pp. 497-513. London: Academic
3. Amery L, Sano H, Mannaerts G, Snider J, Van Looy J, et al. 2001. Identification of PEX5p-related novel peroxisome-targeting signal 1 (PTS1)-binding proteins in mammals. Biochem. J. 357:635-46
4. Aubourg P, Scotto J, Rocchiccioli F, Feldmann-Pautrat D, Robain O. 1986. Neonatal adrenoleukodystrophy. J. Neurol. Neurosurg. Psychiatr. 49:77-86
5. Baes M, Gressens P, Baumgart E, Carmeliet P, Casteels M, et al. 1997. A mouse model for Zellweger syndrome. Nat. Genet. 17:49-57
6. Baes M, Dewerchin M, Janssen A, Collen D, Carmeliet P. 2002. Generation of Pex5-loxP mice allowing the conditional elimination of peroxisomes. Genesis 32:177-78
7. Barkovich AJ, Peck WW. 1997. MR of Zellweger syndrome. Am. J. Neuroradiol. 18:1163-70
8. Barnett P, Tabak HF, Hettema EH. 2000. Nuclear receptors arose from preexisting protein modules during evolution. TIBS 25:227-28
9. Barth PG, Gootjes J, Bode H, Vreken P, Majoie CB, Wanders RJ. 2001. Late onset white matter disease in peroxisome biogenesis disorder. Neurology 57: 1949-55
10. Baumgart E, Vanhorebeek I, Grabenbauer M, Borgers M, Declercq PE, et al. 2001. Mitochondrial alterations caused by defective peroxisomal biogenesis in a mouse model for Zellweger syndrome (PEX5 knockout mouse). Am. J. Pathol. 159:1477-94
11. Baumgartner MR, Poll-The BT, Verhoeven NM, Jakobs C, Espeel M, et al. 1998. Clinical approach to inherited peroxisomal disorders: A series of 27 patients. Ann. Neurol. 44:720-30
12. Baumgartner MR, Saudubray J-M. 2002. Peroxisomal disorders. Semin. Neonatol. 7:85-94
13. Bellion E, Goodman JM. 1987. Proton ionophores prevent assembly of a peroxisomal protein. Cell 48:165-73
14. Berger J, Moller DE. 2002. The mechanisms of action of PPARs. Annu. Rev. Med. 53:409-35
15. Biardi L, Krisans SK. 1996. Compartmentalization of cholesterol biosynthesis. J. Biol. Chem. 271:1784-88
16. Biermanns M, Gärtner J. 2001. Targeting elements in the amino-terminal part direct the human 70-kDa peroxisomal integral membrane protein (PMP70) to peroxisomes. Biochem. Biophys. Res. Comm. 285:649-55
17. Bjorkman J, Tonks I, Maxwell MA, Paterson C, Kay GF, Crane DI. 2002. Conditional inactivation of the peroxisome biogenesis Pex13 gene by Cre-loxP excision. Genesis 32:179-80
18. Bottger G, Barnett P, Klein ATJ, Kragt A, Tabak HF, Distel B. 2000. Saccharomyces cerevisiae PTS1 receptor Pex5p interacts with the SH3 domain of the peroxisomal membrane protein Pex13p in an unconventional, non-PXXXP-related manner. Mol. Biol. Cell 11:3963-76
19. Bowen P, Lee CSN, Zellweger H, Lindenberg R. 1964. A familial syndrome of multiple congenital anomalies. Bull. Johns Hopkins Hosp. 114:402-4
20. Braverman N, Steel G, Obie C, Moser A, Moser H, et al. 1997. Human PEX7 encodes the peroxisomal PTS2 receptor and is responsible for rhizomelic chondrodysplasia punctata. Nat. Genet. 15:369-76
21. Braverman N, Dodt G, Gould SJ, Valle D. 1998. An isoform of Pex5p, the human PTS1 receptor, is required for the import of PTS2 proteins into peroxisomes. Hum. Mol. Genet. 7:1195-205
22. Braverman N, Chen L, Lin P, Obie C, Steel G, et al. 2002. Mutation analysis of PEX7 in 60 probands with rhizomelic chondrodysplasia punctata and functional correlations of genotype with phenotype. Hum. Mutat 20:284-97
23. Brocard CB, Jedeszko C, Song HC, Terlecky SR, Walton PA. 2003. Protein structure and import into the peroxisomal matrix. Traffic 4:74-82
24. Brosius U, Dehmel T, Gärtner J. 2002. Two different targeting signals direct human peroxisomal membrane protein 22 to peroxisomes. J. Biol. Chem. 277:774-84
25. Brown TW, Titorenko VI, Rachubinski RA. 2000. Mutants of the Yarrowia lipolytica PEX23 gene encoding an integral peroxisomal membrane peroxin mislocalize matrix proteins and accumulate vesicles containing peroxisomal matrix and membrane proteins. Mol. Biol. Cell 11:141-52
26. Brul S, Westerveld A, Strijland A, Wanders RJA, Schram AW, et al. 1988. Genetic heterogeneity in the cerebrohepatorenal (Zellweger) syndrome and other inherited disorders with a generalized impairment of peroxisomal functions. A study using complementation analysis. J. Clin. Invest. 81:1710-15
27. Chang C-C, Lee W-H, Moser H, Valle D, Gould SJ. 1997. Isolation of the human PEX12 gene, mutated in group 3 of the peroxisome biogenesis disorders. Nat. Genet. 15:385-88
28. Chang C-C, Gould SJ. 1998. Phenotype-genotype relationships in complementation group 3 of the peroxisome-biogenesis disorders. Am. J. Hum. Genet. 63:1294-306
29. Chang C-C, Warren DS, Sacksteder KA, Gould SJ. 1999. PEX12 interacts with PEX5 and PEX10 and acts downstream of receptor docking in peroxisomal matrix protein import. J. Cell Biol. 147:761-73
30. Chang CC, South S, Warren D, Jones J, Moser AB, et al. 1999. Metabolic control of peroxisome abundance. J. Cell Sci. 112:1579-90
31. Collins CS, Gould SJ. 1999. Identification of a common mutation in severely affected PEX1-deficient patients. Hum. Mutat. 14:45-53
32. Collins CS, Kalish JE, Morrell JC, Gould SJ. 2000. The peroxisome biogenesis factors Pex4p, Pex22p, Pex1p, and Pex6p act in the terminal steps of peroxisomal matrix protein import. Mol. Cell Biol. 20:7516-26
33. Craigen WJ. 2001. Mouse models of human genetic disorders. In The Metabolic and Molecular Bases of Inherited Disease, ed. CR Scriver, AL Beaudet, WS Sly, D Valle, pp. 379-415. New York: McGraw-Hill
34. Crane DI, Kalish JE, Gould SJ. 1994. The Pichia pastoris PAS4 gene encodes a ubiquitin-conjugating enzyme required for peroxisome assembly. J. Biol. Chem. 269:21835-44
35. Dammai V, Subramani S. 2001. The human peroxisomal targeting signal receptor, Pex5p, is translocated into the peroxisomal matrix and recycled to the cytosol. Cell 105:187-96
36. Dansen TB, Wirtz KW, Wanders RJ, Pap EH. 2000. Peroxisomes in human fibroblasts have a basic pH. Nat. Cell Biol. 2:51-53
37. de Vet ECJM, IJ L 1st, Oostheim W, Wanders RJA, van den Bosch H. 1998. Alkyl-dihydroxyacetonephosphate synthase: Fate in peroxisome biogenesis disorders and identification of the point mutation underlying a single enzyme deficiency. J. Biol. Chem. 273:10296-301
38. Denning GM, Anderson MP, Amara JF, Marshall J, Smith AE, Welsh MJ. 1992. Processing of mutant cystic fibrosis transmembrane conductance regulator is temperature-sensitive. Nature 358:709-10
39. Depreter M, Vandesompele J, Espeel M, Speleman F, Roels F. 2002. Modulation of the peroxisomal gene expression pattern by dehydroepiandrosterone and vitamin D: Therapeutic implications. J. Endocrinol. 175:779-92
40. Dimmick JE. 1997. Pathology of peroxisomal disorders. In Organelle Diseases, ed. DA Applegarth, JE Dimmick, JC Hall, pp. 211-32. London: Chapman & Hall Medical
41. Distel B, Erdmann R, Gould SJ, Blobel G, Crane DI, et al. 1996. A unified nomenclature for peroxisome biogenesis factors. J. Cell Biol. 135:1-3
42. Dodt G, Braverman N, Wong C, Moser A, Moser HW, et al. 1995. Mutations in the PTS1 receptor gene, PXR1, define complementation group 2 of the peroxisome biogenesis disorders. Nat. Genet. 9:115-24
43. Dodt G, Braverman N, Valle D, Gould SJ. 1996. From expressed sequence tags to peroxisome biogenesis disorder genes. Ann. NY Acad. Sci. 804:516-23
44. Dodt G, Gould SJ. 1996. Multiple PEX genes are required for proper subcellular distribution and stability of Pex5p, the PTS1 receptor: Evidence that PTS1 protein import is mediated by a cycling receptor. J. Cell Biol. 135:1763-74
45. Dodt G, Warren DS, Becker E, Rehling P, Gould SJ. 2001. Domain mapping of human PEX5 reveals functional and structural similarities to Saccharomyces cerevisiae Pex18p and Pex21p. J. Biol. Chem. 276:41769-81
46. Douangamath A, Filipp FV, Klein ATJ, Barnett P, Zou P, et al. 2002. Topography for independent binding of alpha-helical and PPII-helical ligands to a peroxisomal SH3 domain. Mol. Cell 10:1007-17
47. Dyer JM, McNew JA, Goodman JM. 1996. The sorting sequence of the peroxisomal integral membrane protein PMP47 is contained within a short hydrophilic loop. J. Cell Biol. 133:269-80
48. Einwachter H, Sowinski S, Kunau WH, Schliebs W. 2001. Yarrowia lipolyticas Pex20p, Saccharomyces cerevisiae Pex18p/Pex21p and mammalian Pex5pL fulfill a common function in the early steps of the peroxisomal PTS2 import pathway. EMBO Rep. 2:1035-39
49. Eitzen GA, Aitchison JD, Szilard RK, Veenhuis M, Nuttley MW, Rachubinski RA. 1995. The Yarrowia lipolytica gene PAY2 encodes a 42-kDa peroxisomal integral membrane protein essential for matrix protein import and peroxisome enlargement but not for peroxisome membrane proliferation. J. Biol. Chem. 270:1429-36
50. Elgersma Y, Kwast L, Klein A, Voorn-Brouwer T, van den Berg M, et al. 1996. The SH3 domain of the Saccharomyces cerevisiae peroxisomal membrane protein Pex13p functions as a docking site for Pex5p, a mobile receptor for the import of PTS1-containing proteins. J. Cell Biol. 135:97-109
51. Elgersma Y, Kwast L, van den Berg M, Snyder WB, Distel B, et al. 1997. Overexpression of Pex15p, a phosphorylated peroxisomal integral membrane protein required for peroxisome assembly in S. cerevisiae, causes proliferation of the endoplasmic reticulum membrane. EMBO J. 16:7326-41
52. Erdmann R, Wiebel FF, Flessau A, Rytka J, Beyer A, et al. 1991. PAS1, a yeast gene required for peroxisome biogenesis, encodes a member of a novel family of putative ATPases. Cell 64:499-510
53. Erdmann R, Blobel G. 1995. Giant peroxisomes in oleic acid-induced Saccharomyces cerevisiae lacking the peroxisomal membrane protein Pmp27p. J. Cell Biol. 128:509-23
54. Erdmann R, Blobel G. 1996. Identification of Pex13p, a peroxisomal membrane receptor for the PTS1 recognition factor. J. Cell Biol. 135:111-21
55. Espeel M, Mandel H, Poggi F, Smeitink JA, Wanders RJ, et al. 1995. Peroxisome mosaicism in the livers of peroxisomal deficiency patients. Hepatology 22:497-504
56. Faber KN, Heyman JA, Subramani S. 1998. Two AAA family peroxins, PpPex1p and PpPex6p, interact with each other in an ATP-dependent manner and are associated with different subcellular membranous structures distinct from peroxisomes. Mol. Cell Biol. 18: 936-43
57. Faber KN, Haan GJ, Baerends RJS, Kram AM, Veenhuis M. 2002. Normal peroxisome development from vesicles induced by truncated Hansenula polymorpha Pex3p. J. Biol. Chem. 277:11026-33
58. Faust PL, Hatten ME. 1997. Targeted deletion of the PEX2 peroxisome assembly gene in mice provides a model for Zellweger syndrome, a human neuronal migration disorder. J. Cell Biol. 139: 1293-305
59. Faust PL, Su H-M, Moser A, Moser HW. 2001. The peroxisome deficient PEX2 Zellweger mouse. J. Mol. Neurosci. 16:289-97
60. Ferdinandusse S, Denis S, Mooijer P, Zhang Z, Reddy JK, et al. 2001. Identification of the peroxisomal β-oxidation enzymes involved in the biosynthesis of docosahexaenoic acid. J. Lipid Res. 42: 1987-95
61. Ferdinandusse S, Meissner T, Wanders RJ, Mayatepek E. 2002. Identification of the peroxisomal β-oxidation enzymes involved in the degradation of leukotrienes. Biochem. Biophys. Res. Comm. 293:269-73
62. Fourie DT. 1995. Chondrodysplasia punctata: Case report and literature review of patients with heart lesions. Pediatr. Cardiol. 16:247-50
63. Fransen M, Brees C, Baumgart E, Vanhooren JCT, Baes M, et al. 1995. Identification and characterization of the putative human peroxisomal C-terminal targeting signal import receptor. J. Biol. Chem. 270:7731-36
64. Fransen M, Wylin T, Brees C, Mannaerts G, Van Veldhoven PP. 2001. Human pex19p binds peroxisomal integral membrane proteins at regions distinct from their sorting sequences. Mol. Cell Biol. 21:4413-24
65. Fransen M, Brees C, Ghys K, Amery L, Mannaerts G, et al. 2002. Analysis of mammalian peroxin interactions using a non-transcription-based bacterial two-hybrid assay. Mol. Cell Proteomics 1:243-52
66. Fujiwara C, Imamura A, Hashiguchi N, Shimozawa N, Suzuki Y, et al. 2000. Catalase-less peroxisomes. Implication in the milder forms of peroxisome biogenesis disorders. J. Biol. Chem. 275:37271-77
67. Fukuda S, Shimozawa N, Suzuki Y, Zhang Z, Tomatsu S, et al. 1996. Human peroxisome assembly factor-2 (PAF-2): A gene responsible for Group C peroxisome biogenesis disorder in humans. Am. J. Hum. Genet. 59:1210-20
68. Gámez A, Pérez B, Ugarte M, Desviat LR. 2000. Expression analysis of phenylketonuria mutations. J. Biol. Chem. 275: 29737-42
69. Gatto GJ Jr, Geisbrecht BV, Gould SJ, Berg JM. 2000. A proposed model for the PEX5-peroxisomal targeting signal-1 recognition complex. Proteins 38:241-46
70. Gatto GJ Jr, Geisbrecht BV, Gould SJ, Berg JM. 2000. Peroxisomal targeting signal-1 recognition by the TPR domains of human PEX5. Nat. Struct. Biol. 7:1091-95
71. Gatto GJ Jr, Maynard EL, Guerrerio AL, Geisbrecht BV, Gould SJ, Berg JM. 2003. Correlating structure and affinity for PEX5:PTS1 complexes. Biochemistry 42:1660-66
72. Geisbrecht BV, Collins CS, Reuber BE, Gould SJ. 1998. Disruption of a PEX1-PEX6 interaction is the most common cause of the neurologic disorders Zellweger syndrome, neonatal adrenoleukodystrophy, and infantile Refsum disease. Proc. Natl. Acad. Sci. USA 95:8630-35
73. Ghaedi K, Honsho M, Shimozawa N, Suzuki Y, Kondo N, Fujiki Y. 2000. PEX3 is the causal gene responsible for peroxisome membrane assembly-defective Zellweger syndrome of complementation group G. Am. J. Hum. Genet. 67:976-81
74. Ghys K, Fransen M, Mannaerts G, Van Veldhoven PP. 2002. Functional studies on human Pex7p: Subcellular localization and interaction with proteins containing a peroxisome-targeting signal type 2 and other peroxins. Biochem. J. 365:41-50
75. Giros M, Roels F, Prats J, Ruiz M, Ribes A, et al. 1996. Long survival in a case of peroxisomal biogenesis disorder with peroxisome mosaicism in the liver. Ann. NY Acad. Sci. 804:747-49
76. Girzalsky W, Rehling P, Stein K, Kipper J, Blank L, et al. 1999. Involvement of Pex13p in Pex14p localization and peroxisomal targeting signal 2-dependent protein import into peroxisomes. J. Cell Biol. 144:1151-62
77. Glover JR, Andrews DW, Rachubinski RA. 1994. Saccharomyces cerevisiae peroxisomal thiolase is imported as a dimer. Proc. Natl. Acad. Sci. USA 91:10541-45
78. Goldfischer S, Moore CL, Johnson AB, Spiro AJ, Valsmis MP, et al. 1973. Peroxisomal and mitochondrial defects in the cerebro-hepato-renal syndrome. Science 182:62-64
79. Gootjes J, Mooijer PA, Dekker C, Barth PG, Poll-The BT, et al. 2002. Biochemical markers predicting survival in peroxisome biogenesis disorders. Neurology 59:1746-49
80. Gotte K, Girzalsky W, Linkert M, Baumgart E, Kammerer S, et al. 1998. Pex19p, a farnesylated protein essential for peroxisome biogenesis. Mol. Cell Biol. 18:616-28
81. Gould SJ, Keller GA, Hosken N, Wilkinson J, Subramani S. 1989. A conserved tripeptide sorts proteins to peroxisomes. J. Cell Biol. 108:1657-64
82. Gould SJ, Kalish JE, Morrell JC, Bjorkman J, Urquhart AJ, Crane DI. 1996. Pex13p is an SH3 protein of the peroxisome membrane and a docking factor for the predominantly cytoplasmic PTS1 receptor. J. Cell Biol. 135:85-95
83. Gould SJ, Valle D. 2000. Peroxisome biogenesis disorders: Genetics and cell biology. TIGS 16:340-44
84. Gould SJ, Raymond GV, Valle D. 2001. The peroxisome biogenesis disorders. In The Metabolic and Molecular Bases of Inherited Disease, ed. CR Scriver, AL Beaudet, WS Sly, D Valle, pp. 3181-217. New York: McGraw-Hill
85. Gould SJ, Collins CS. 2002. Peroxisomal-protein import: Is it really that complex? Nat. Rev. Mol. Cell Biol. 3:382-89
86. Gouveia AM, Reguenga C, Oliveira ME, Sa-Miranda C, Azevedo JE. 2000. Characterization of peroxisomal Pex5p from rat liver. Pex5p in the Pex5p-Pex14p membrane complex is a transmembrane protein. J. Biol. Chem. 275:32444-51
87. Gouveia AM, Guimarães CP, Oliveira ME, Reguenga C, Sá-Miranda C, Azevedo JE. 2003. Characterization of the peroxisomal cycling receptor, Pex5p, using a cell-free in vitro import system. J. Biol Chem. 278:226-32
88. Gouveia AM, Guimarães CP, Oliveira ME, Sá-Miranda C, Azevedo JE. 2003. Insertion of Pex5p into the peroxisomal membrane is cargo protein-dependent. J. Biol. Chem. 278:4389-92
89. Gregersen N, Bross P, Andresen BS, Pedersen CB, Corydon TJ, Bolund L. 2001. The role of chaperone-assisted folding and quality control in inborn errors of metabolism: Protein folding disorders. J Inherit. Metab. Dis. 24:189-212
90. Gressens P, Baes M, Leroux P, Lombet A, Van Veldhoven PP, et al. 2000. Neuronal migration disorder in Zellweger mice is secondary to glutamate receptor dysfunction. Ann. Neurol. 48:336-43
91. Harano T, Nose S, Uezu R, Shimizu N, Fujiki Y. 2001. Hsp70 regulates the interaction between the peroxisome targeting signal type 1 (PTS1)-receptor Pex5p and PTS1. Biochem. J. 357:157-65
92. Harper CC, South ST, McCaffery JM, Gould SJ. 2002. Peroxisomal membrane protein import does not require Pex17p. J. Biol. Chem. 277:16498-504
93. Harper CC, Berg JM, Gould SJ. 2003. PEX5 binds the PTS1 independently of Hsp70 and the peroxin PEX12. J. Biol. Chem. 278:7897-7901
94. Hashiguchi N, Kojidani T, Imanaka T, Haraguchi T, Hiraoka Y, et al. 2002. Peroxisomes are formed from complex membrane structures in PEX6-deficient CHO cells upon genetic complementation. Mol. Biol. Cell 13:711-22
95. Hettema EH, Ruigrok CCM, Koerkamp MG, van den Berg M, Tabak HF, et al. 1998. The cytosolic DnaJ-like protein Djp1p is involved specifically in peroxisomal protein import. J. Cell Biol. 142:421-34
96. Hettema EH, Girzalsky W, van Den Berg M, Erdmann R, Distel B. 2000. Saccharomyces cerevisiae pex3p and pex19p are required for proper localization and stability of peroxisomal membrane proteins. EMBO J. 19:223-33
97. Heyman JA, Mononsov E, Subramani S. 1994. Role of the PAS1 gene of Pichia pastoris in peroxisome biogenesis. J. Cell Biol. 127: 1259-73
98. Hoepfner D, van den Berg M, Philippsen P, Tabak HF, Hettema EH. 2001. A role for Vps1p, actin and the Myo2p motor in peroxisome abundance and inheritance in Saccharomyces cerevisiae. J. Cell Biol. 155:979-90
99. Hogenboom S, Romeijn GJ, Houten SM, Baes M, Wanders RJ, Waterham HR. 2002. Absence of functional peroxisomes does not lead to deficiency of enzymes involved in cholesterol biosynthesis. J. Lipid Res. 43:90-98
100. Honsho M, Tamura S, Shimozawa N, Suzuki Y, Kondo N, Fujiki Y. 1998. Mutation in PEX16 is causal in the peroxisome-deficient Zellweger syndrome of complementation group D. Am. J. Hum. Genet. 63:1622-30
101. Honsho M, Hiroshige T, Fujiki Y. 2002. The membrane biogenesis peroxin Pex16p. J. Biol. Chem. 277:44513-24
102. Huang Y, Ito R, Miura S, Hashimoto T, Ito M. 2000. A missense mutation in the RING finger motif of PEX2 protein disturbs the import of peroxisome targeting signal 1 (PTS1)-containing protein but not the PTS2-containing protein. Biochem. Biophys. Res. Comm. 270: 717-21
103. Huhse B, Rehling P, Albertini M, Blank L, Meller K, Kunau W-H. 1998. Pex17p of Saccharomyces cerevisiae is a novel peroxin and component of the peroxisomal protein translocation machinery. J. Cell Biol. 140:49-60
104. Igarashi M, Schaumburg HH, Powers J, Kishmoto Y, Kolodny E, Suzuki K. 1976. Fatty acid abnormality in adrenoleukodystrophy. J. Neurochem. 26:851-60
105. Imamura A, Tamura S, Shimozawa N, Suzuki N, Zhang Z, et al. 1998. Temperature-sensitive mutation in PEX1 moderates the phenotypes of peroxisome deficiency disorders. Hum. Mol. Genet. 7: 2089-94
106. Imamura A, Shimozawa N, Suzuki Y, Zhang Z, Tsukamoto T, et al. 2000. Restoration of biochemical function of the peroxisome in the temperature-sensitive mild forms of peroxisome biogenesis disorder in humans. Brain Dev. 22:8-12
107. Imamura A, Shimozawa N, Suzuki Y, Zhang Z, Tsukamoto T, et al. 2000. Temperature-sensitive mutation of PEX6 in peroxisome biogenesis disorders in complementation group C (CG-C): Comparative study of PEX6 and PEX1. Pediatr. Res. 48:541-45
108. Infante JP, Huszagh VA. 2001. Zellweger syndrome knockout mouse models challenge putative peroxisomal b-oxidation involvement in docosahexaenoic acid (22:6n-3) biosynthesis. Mol. Genet. Metab. 72:1-7
109. Jankowksi A, Kim JH, Collins RF, Daneman R, Walton P, Grinstein S. 2001. In situ measurements of the pH of mammalian peroxisomes using the fluorescent protein pHluorin. J. Biol. Chem. 276:48748-53
110. Janssen A, Baes M, Gressens P, Mannaerts G, Declercq PE, Van Veldhoven PP. 2000. Docosahexaenoic acid deficit is not a major pathogenic factor in peroxisome-deficient mice. Lab. Invest. 80:31-35
111. Jones JM, Morrell JC, Gould SJ. 2001. Multiple distinct targeting signals in integral peroxisomal membrane proteins. J. Cell Biol. 153:1141-49
112. Kalish JE, Theda C, Morrell JC, Berg JM, Gould SJ. 1995. Formation of the peroxisome lumen is abolished by loss of Pichia pastoris Pas7p, a zinc binding integral membrane protein of the peroxisome. Mol. Cell Biol. 15:6406-19
113. Kalish JE, Keller GA, Morrell JC, Mihalik SJ, Smith B, et al. 1996. Characterization of a novel component of the peroxisomal protein import apparatus using fluorescent peroxisomal proteins. EMBO J. 15:3275-85
114. Kemp S, Wei HM, Lu JF, Braiterman LT, McGuinness MC, et al. 1998. Gene redundancy and pharmacologic gene therapy: Implications for X-linked adrenoleukodystrophy. Nat. Med. 4:1261-68
115. Kersten S, Desvergne B, Wahli W. 2000. Roles of PPARs in health and disease. Nature 405:421-24
116. Khanna AJ, Braverman N, Valle D, Sponseller PD. 2001. Cervical stenosis secondary to rhizomelic chondrodysplasia punctata. Am. J. Med. Genet. 99:63-66
117. Kiel JA, Hilbrands RE, van der Klei IJ, Rasmussen SW, Salomons FA, et al. 1999. Hansenula polymorpha Pex1p and Pex6p are peroxisome-associated AAA proteins that functionally and physically interact. Yeast 15:1059-78
118. Klein ATJ, Barnett P, Bottger G, Konings D, Tabak HF, Distel B. 2001. Recognition of peroxisomal targeting signal type 1 by the import receptor Pex5p. J. Biol. Chem. 276:15034-41
119. Koch A, Thiemann M, Grabenbauer M, Yoon Y, McNiven MA, Schrader M. 2003. Dynamin-like protein 1 is involved in peroxisomal fission. J. Biol. Chem. 278:8597-605
120. Koller A, Snyder WB, Faber KN, Wenzel TJ, Rangell L, et al. 1999. Pex22p of Pichia pastoris, essential for peroxisomal matrix protein import, anchors the ubiquitin-conjugating enzyme, Pex4p, on the peroxisomal membrane. J. Cell Biol. 146:99-112
121. Kunau W-H, Erdmann R. 1998. Peroxisome biogenesis: Back to the endoplasmic reticulum? Curr. Biol. 8:R299-R302
122. Kunau WH. 1998. Peroxisome biogenesis: from yeast to man. Curr. Opin. Microbiol. 1:232-37
123. Kunau WH. 2001. Peroxisomes: The extended shuttle to the peroxisome matrix. Curr. Biol. 11:R659-62
124. Lazarow PB, Robbi M, Fujiki Y, Wong L. 1982. Biogenesis of peroxisomal proteins in vivo and in vitro. Ann. NY Acad. Sci. 386:285-300
125. Lazarow PB, Fujiki Y. 1985. Biogenesis of peroxisomes. Annu. Rev. Cell Biol. 1:489-530
126. Li X, Baumgart E, Dong G-X, Morrell JC, Jimenez-Sanchez G, et al. 2002. PEX11α is required for peroxisome proliferation in response to 4-phenylbutyrate but is dispensable for peroxisome proliferator-activated receptor alpha-mediated peroxisome proliferation. Mol. Cell Biol. 22:8226-40
127. Li X, Baumgart E, Morrell JC, Jimenez-Sanchez G, Valle D, Gould SJ. 2002. PEX11β deficiency is lethal and impairs neuronal migration but does not abrogate peroxisome function. Mol. Cell Biol. 22: 4358-65
128. Li X, Gould SJ. 2002. PEX11 promotes peroxisome division independently of peroxisome metabolism. J. Cell Biol. 156:643-51
129. Li X, Gould SJ. 2003. The dynamin-like GTPase DLP1 is essential for peroxisome division and is recruited to peroxisomes in part by PEX11. J. Biol. Chem. 278:17012-20
130. Liu Y, Björkman J, Urquhart A, Wanders RJA, Crane DI, Gould SJ. 1999. PEX13 is mutated in complementation group 13 of peroxisome biogenesis disorders. Am. J. Hum. Genet. 65:621-34
131. Maeda K, Kimura A, Yamato Y, Nittono H, Takei H, et al. 2002. Oral bile acid treatment in two Japanese patients with Zellweger syndrome. J. Pediatr. Gastroenterol. Nutr. 35:227-30
132. Maier AG, Schulreich S, Bremser M, Clayton C. 2000. Binding of coatomer by the PEX11 C-terminus is not required for function. FEBS Lett. 484:82-86
133. Mandel H, Espeel M, Roels F, Sofer N, Luder A, et al. 1994. A new type of peroxisomal disorder with variable expression in liver and fibroblasts. J. Pediatr. 125:549-55
134. Marshall PA, Krimkevich YI, Lark RH, Dyer JM, Veenhuis M, Goodman JM. 1995. Pmp27 promotes peroxisomal proliferation. J. Cell Biol. 129:345-55
135. Martinez M. 2001. Restoring the DHA levels in the brains of Zellweger patients. J. Mol. Neurosci. 16:309-16
136. 135a. Matsumoto N, Tamura S, Fujiki Y. 2003. The pathogenic peroxin Pex26p recruits the Pex1p-Pex6p AAA ATPase complexes to peroxisomes. Nat. Cell. Biol. 5:454-60
137. Matsuzono Y, Kinoshita N, Tamura S, Shimozawa N, Hamasaki M, et al. 1999. Human PEX19: cDNA cloning by functional complementation, mutation analysis in a patient with Zellweger syndrome and potential role in peroxisomal membrane assembly. Proc. Natl. Acad. Sci. USA 96:2116-21
138. Maxwell MA, Allen T, Solly PB, Svingen T, Paton BC, Crane DI. 2002. Novel PEX1 mutations and genotype-phenotype correlations in Australasian peroxisome biogenesis diorder patients. Hum. Mutat. 20:342-51
139. Mayerhofer PU, Kattenfeld T, Roscher AA, Muntau AC. 2002. Two splice variants of human PEX19 exhibit distinct functions in peroxisomal assembly. Biochem. Biophys. Res. Comm. 291: 1180-86
140. McCollum D, Monosov E, Subramani S. 1993. The pas8 mutant of Pichia pastoris exhibits the peroxisomal protein import deficiencies of Zellweger syndrome cells. The PAS8 protein binds to the COOH-terminal tripeptide peroxisomal targeting signal and is a member of the TPR protein family. J. Cell Biol. 121:761-74
141. McNew JA, Goodman JM. 1994. An oligomeric protein is imported into peroxisomes in vivo. J. Cell Biol. 127:1245-57
142. Moser A, Borel J, Odone A, Naidu S, Cornblath D, et al. 1987. A new dietary therapy for adrenoleukodystrophy: Biochemical and preliminary clinical results in 36 patients. Ann. Neurol. 21:240-49
143. Moser AB, Rasmussen M, Naidu S, Watkins PA, McGuinness M, et al. 1995. Phenotype of patients with peroxisomal disorders subdivided into sixteen complementation groups. J. Pediatr. 127:13-22
144. Moser AB, Jones DS, Raymond GV, Moser HW. 1999. Plasma and red blood cell fatty acids in peroxisomal disorders. Neurochem. Res. 24:187-97
145. Moser HW. 1999. Genotype-phenotype correlations in disorders of peroxisome biogenesis. Mol. Genet. Metab. 68:316-27
146. Moser HW, Smith KD, Watkins PA, Powers JM, Moser AB. 2001. X-linked adrenoleukodystrophy. In The Metabolic and Molecular Bases of Inherited Disease, ed. CR Scriver, AL Beaudet, WS Sly, D Valle, pp. 3257-302. New York: McGraw-Hill
147. Motley A, Hettema E, Distel B, Tabak H. 1994. Differential protein import deficiencies in human peroxisome assembly disorders. J. Cell Biol. 125:755-67
148. Motley AM, Hettema EH, Hogenhout EM, Brites P, ten Asbroek ALMA, et al. 1997. Rhizomelic chondrodysplasia punctata is a peroxisomal protein targeting disease caused by a nonfunctional PTS2 receptor. Nat. Genet. 15:377-80
149. Motley AM, Brites P, Gerez L, Hogenhout E, Haasjes J, et al. 2002. Mutational spectrum in the PEX7 gene and functional analysis of mutant alleles in 78 patients with rhizomelic chondrodysplasia punctata type 1. Am. J. Hum. Genet. 70:612-24
150. Mukai S, Ghaedi K, Fujiki Y. 2002. Intracellular localization, function and dysfunction of theperoxisome-targeting signal type 2 receptor, Pex7p, in mammalian cells. J. Biol. Chem. 277:9548-61
151. Muntau AC, Holzinger A, Mayerhofer PU, Gartner J, Roscher AA, Kammerer S. 2000. The human PEX3 gene encoding a peroxisomal assembly protein: genomic organization, positional mapping, and mutation analysis in candidate phenotypes. Biochem. Biophys. Res. Comm. 268:704-10
152. Muntau AC, Mayerhofer PU, Paton BC, Kammerer S, Roscher AA. 2000. Defective peroxisome membrane synthesis due to mutations in human PEX3 causes Zellweger Syndrome, complementation group G. Am. J. Hum. Genet. 67:967-75
153. Ofman R, Hettema EH, Hogenhout EM, Caruso U, Muijsers AO, Wanders RJA. 1998. Acyl-CoA:dihydroxyacetonephosphate acyltransferase: Cloning of the human cDNA and resolution of the molecular basis in rhizomelic chondrodysplasia punctata type 2. Hum. Mol. Genet. 7:847-53
154. Ogura T, Wilkinson AJ. 2001. AAA+ superfamily ATPases: Common structure-diverse function. Genes Cells 6:575-97
155. Okumoto K, Itoh R, Shimozawa N, Suzuki Y, Tamura S, et al. 1998. Mutations in PEX10 is the cause of Zellweger peroxisome deficiency syndrome of complementation group B. Hum. Mol. Genet. 7:1399-405
156. Okumoto K, Shimozawa N, Kawai A, Tamura S, Tsukamoto T, et al. 1998. PEX12, the pathogenic gene of group III Zellweger syndrome: cDNA cloning by functional complementation on a CHO cell mutant, patient analysis, and characterization of PEX12p. Mol. Cell Biol. 18:4324-36
157. Okumoto K, Abe I, Fujiki Y. 2000. Molecular anatomy of the peroxin Pex12p: Ring finger domain is essential for Pex12p function and interacts with the peroxisome-targeting signal type 1-receptor Pex5p and a ring peroxin, Pex10p. J. Biol. Chem. 275:25700-10
158. Oliveira ME, Reguenga C, Gouveia AM, Guimarães CP, Schliebs W, et al. 2002. Mammalian Pex14p: Membrane topology and characterisation of the Pex14p-Pex14p interaction. Biochim. Biophys. Acta 1567:13-22
159. Olivier LM, Krisans SK. 2000. Peroxisomal protein targeting and identification of peroxisomal targeting signals in cholesterol biosynthetic enzymes. Biochim. Biophys. Acta 1529:89-102
160. Opitz JM, ZuRhein GM, Vitale L, Shahidi NT, Howe JJ, et al. 1969. The Zellweger syndrome (cerebrohepatorenal syndrome). Birth Defects 5:144
161. Osumi T, Tsukamoto T, Hata S, Yokota S, Miura S, et al. 1991. Amino-terminal presequence of the precursor of peroxisomal 3-ketoacyl-CoA thiolase is a cleavable signal peptide for peroxisomal targeting. Biochem. Biophys. Res. Comm. 181:947-54
162. Osumi T, Imamura A, Tsukamoto T, Fujiwara C, Hashiguchi N, et al. 2000. Temperature sensitivity in peroxisome assembly processes characterizes milder forms of peroxisome biogenesis disorders. Cell Biochem. Biophys. 32:165-70
163. Otera H, Okumoto K, Tateishi K, Ikoma Y, Matsuda E, et al. 1998. Peroxisome targeting signal type 1 (PTS1) receptor is involved in import of both PTS1 and PTS2: Studies with PEX5-defective CHO cell mutants. Mol. Cell Biol. 18:388-99
164. Otera H, Harano T, Honsho M, Ghaedi K, Mukai S, et al. 2000. The mammalian peroxin Pex5pL, the longer isoform of the mobile peroxisome targeting signal (PTS) type 1 transporter, translocates the Pex7p PTS2 protein complex into peroxisomes via its initial docking site, Pex14p. J. Biol. Chem. 275:21703-14
165. Otera H, Setoguchi K, Hamasaki D, Kumashiro T, Shimizu N, Fujiki Y. 2002. Peroxisomal targeting signal receptor Pex5p interacts with cargoes and import machinery components in a spatiotemporally differentiated manner: Conserved Pex5p WXXXF/Y motifs are critical for matrix protein import. Mol. Cell Biol. 22:1639-55
166. Passarge E, McAdams AJ. 1967. Cerebro-hepato-renal syndrome: A newly recognized hereditary disorder of multiple congenital defects, including sudanophilic leukodystrophy, cirrhosis of the liver and poly cystic kidneys. J. Pediatr. 71:691-702
167. Passreiter M, Anton M, Lay D, Frank R, Harter C, et al. 1998. Peroxisome biogenesis: Involvement of ARF and coatomer. J. Cell Biol. 141:373-83
168. Pause B, Saffrich R, Hunziker A, Ansorge W, Just WW. 2000. Targeting of the 22 kDa integral peroxisomal membrane protein. FEBS Lett. 471:23-28
169. Pineda M, Girós M, Roels F, Espeel M, Ruiz M, et al. 1999. Diagnosis and follow-up of a case of peroxisomal disorder with peroxisomal mosaicism. J. Child Neurol. 14:434-39
170. Poll-The BT, Billette de Villemeur T, Abitbol M, Dufier JL, Saudubray J-M. 1992. Metabolic pigmentary retinopathies: Diagnosis and therapeutic attempts. Eur. J. Pediatr. 151:2-11
171. Portsteffen H, Beyer A, Becker E, Epplen C, Pawlak A, et al. 1997. Human PEX1 is mutated in complementation group 1 of the peroxisome biogenesis disorders. Nat. Genet. 17:449-52
172. Poulos A, Sheffield L, Sharp P, Sherwood G, Johnson D, et al. 1988. Rhizomelic chondrodysplasia punctata: Clinical, pathologic and biochemical findings in two patients. J. Pediatr. 113:685-90
173. Powers JM, Schaumberg HH. 1974. Adreno-leukodystrophy (sex-linked Schilder's disease). A pathogenetic hypothesis based on ultrastructural lesions in adrenal cortex, peripheral nerve and testis. Am. J. Pathol. 76:481-91
174. Powers JM, Moser HW, Moser A, Upshur JK, Bradford BF, et al. 1985. Fetal cerebrohepatorenal (Zellweger) syndrome: Dysmorphic, radiologic, biochemical and pathologic findings in four affected fetuses. Hum. Pathol. 16:610-20
175. Powers JM, Tummons RC, Moser AB, Moser HW, Huff DS, Kelley RI. 1987. Neuronal lipidosis and neuoraxonal dystrophy in cerebro-hepato-renal (Zellweger) syndrome. Acta Neuropathol. 73: 333-43
176. Powers JM, Tummons RC, Caviness VSJ, Moser AB, Moser HW. 1989. Structural and chemical alterations in the cerebral maldevelopment of fetal cerebrohepato-renal (Zellweger) syndrome. J. Neuropathol. Exp. Neurol. 48:270-89
177. Powers JM, Kenjarski TP, Moser AB, Moser HW. 1999. Cerebellar atrophy in chronic rhizomelic chondrodysplasia punctata: A potential role for phytanic acid and calcium in the death of its Purkinje cells. Acta Neuropathol. (Berl.) 98: 129-34
178. Powers JM. 2001. Normal and defective neuronal membranes: Structure and function. J. Mol. Neurosci. 16:285-87
179. Preuss N, Brosius U, Biermanns M, Muntau AC, Conzelmann E, Gärtner J. 2002. PEX1 mutations in complementation group 1 of Zellweger spectrum patients correlate with severity of disease. Pediatr. Res. 51:706-14
180. Purdue PE, Zhang JW, Skoneczny M, Lazarow PB. 1997. Rhizomelic chondrodysplasia punctata is caused by deficiency of human PEX7, a homologue of the yeast PTS2 receptor. Nat. Genet. 15: 381-84
181. Purdue PE, Yang X, Lazarow PB. 1998. Pex18p and Pex21p, a novel pair of related peroxins essential for peroxisomal targeting by the PTS2 pathway. J. Cell Biol. 143:1859-69
182. Purdue PE, Lazarow PB. 2001. Peroxisome biogenesis. Annu. Rev. Cell Dev. Biol. 17:701-52
183. Raas-Rothschild A, Wanders RJ, Mooijer PAW, Gootjes J, Waterham HR, et al. 2002. A PEX6-defective peroxisomal biogenesis disorder with severe phenotype in an infant versus mild phenotype resembling Usher syndrome in the affected parents. Am. J. Hum. Genet. 70:1062-68
184. Raymond GV, Moser HW. 1997. Clinical diagnosis and therapy of peroxisomal diseases. In Organelle Diseases, ed. DA Applegarth, JE Dimmick, JC Hall, pp. 169-92. London: Chapman & Hall
185. Reddy JK, Goel SK, Nemali MR, Carrino JJ, Laffer TG, et al. 1986. Transcriptional regulation of peroxisomal fatty acyl-CoA oxidase and enoyl-CoA hydratase/3-hydroxyacyl-CoA dehydrogenase in rat liver by peroxisome proliferators. Proc. Natl. Acad. Sci. USA 83:1747-51
186. Reddy JK, Hashimoto T. 2001. Peroxisomal β-oxidation and peroxisome prolierator-activated receptor α: An adaptive metabolic system. Annu. Rev. Nutr. 21:193-230
187. Reguenga C, Oliveira ME, Gouveia AM, Sa-Miranda C, Azevedo JE. 2001. Characterization of the mammalian peroxisomal import machinery: Pex2p, Pex5p, Pex12p and Pex14p are subunits of the same protein assembly. J. Biol. Chem. 276:29935-42
188. Rehling P, Marzioch M, Niesen F, Wittke E, Veenhuis M, Kunau WH. 1996. The import receptor for the peroxisomal targeting signal 2 (PTS2) in Saccharomyces cerevisiae is encoded by the PAS7 gene. EMBO J. 15:2901-13
189. Rehling P, Skaletz-Rorowski A, Girzalsky W, Voorn-Brouwer T, Franse MM, et al. 2000. Pex8p, an intraperoxisomal peroxin of Saccharomyces cerevisiae required for protein transport into peroxisomes binds the PTS1 receptor pex5p. J. Biol. Chem. 275:3593-602
190. Reuber BE, Collins CS, Germain-Lee E, Morrell JC, Ameritunga R, et al. 1997. Mutations in PEX1 are the most common cause of Zellweger syndrome, neonatal adrenoleukodystrophy and infantile Refsum disease. Nat. Genet. 17:445-48
191. Roels F, Cornelis A, Poll-The BT, Aubourg P, Ogier H, et al. 1986. Hepatic peroxisomes are deficient in infantile refsum disease: A cytochemical study of four cases. Am. J. Med. Genet. 25:257-71
192. Roels F, Espeel M, De Craemer D. 1991. Liver pathology and immunocytochemistry in congenital peroxisomal dieases: A review. J. Inherit. Metab. Dis. 14:853-75
193. Roels F, Tytgat T, Beken S, Giros M, Espeel M, et al. 1996. Peroxisome mosaics in the liver of patients and the regulation of peroxisome expression in rat hepatocyte cultures. Ann. NY Acad. Sci. 804:502-15
194. Roscher AA, Hoefler S, Hoefler G, Paschke E, Paltauf F, et al. 1989. Genetic and phenotypic heterogeneity in disorders of peroxisome biogenesis. A complementation study involving cell lines from 19 patients. Pediatr. Res. 26:67-72
195. Sacksteder KA, Gould SJ. 2000. The genetics of peroxisome biogenesis. Annu. Rev. Genet. 34:623-52
196. Sacksteder KA, Jones JM, South ST, Li X, Liu Y, Gould SJ. 2000. PEX19 binds multiple peroxisomal membrane proteins, is predominantly cytoplasmic, and is required for peroxisome membrane synthesis. J. Cell Biol. 148:931-44
197. Saidowsky J, Dodt G, Kirchberg K, Wegner A, Nastainczyk W, et al. 2001. The di-aromatic pentapeptide repeats of the human peroxisome import receptor PEX5 are separate high affinity binding sites for the peroxisomal membrane protein PEX14. J. Biol. Chem. 276:34524-29
198. Salomons FA, van der Klei IJ, Kram AM, Harder W, Veenhuis M. 1997. Brefeldin A interferes with peroxisomal protein sorting in the yeast Hansenula polymorpha. FEBS Lett. 411:133-39
199. Santos M, Imanaka T, Shio H, Small GM, Lazarow PB. 1988. Peroxisomal membrane ghosts in Zellweger syndrome-aberrant organelle assembly. Science 239:1536-38
200. Santos MJ, Imanaka T, Shio H, Lazarow PB. 1988. Peroxisomal integral membrane proteins in control and Zellweger fibroblasts. J. Biol. Chem. 263:10502-9
201. Schliebs W, Saidowsky J, Agianian B, Dodt G, Herberg FW, Kunau W-H. 1999. Recombinant human peroxisomal targeting signal receptor PEX5. Structural basis for interaction of PEX5 with PEX14. J. Biol. Chem. 274:5666-73
202. Schrader M, Reuber BE, Morell JC, Jimenez-Sanchez G, Obie C, et al. 1998. Expression of PEX11b mediates peroxisome proliferation in the absence of extracellular stimuli. J. Biol. Chem. 273: 29607-14
203. Schutgens RB, Wanders RJ. 1997. Laboratory diagnosis of peroxisomal disorders. In Organelle Diseases, ed. DA Applegarth, JE Dimmick, JC Hall, pp. 193-210. London: Chapman & Hall
204. Scotto JM, Hadchouel M, Odievre M, Laudat MH, Saudubray JM, et al. 1982. Infantile phytanic acid storage disease, a possible variant of Refsum disease: Three cases including ultrastructural studies of the liver. J. Inherit. Metab. Dis. 5:83-90
205. Setchell KD, Bragetti P, Zimmer-Nechemias L, Daugherty C, Pelli MA, et al. 1992. Oral bile acid treatment and the patient with Zellweger syndrome. Hepatology 15:198-207
206. Shimizu N, Itoh R, Hirono Y, Otera H, Ghaedi K, et al. 1999. The peroxin Pex14p. cDNA cloning by functional complementation on a Chinese hamster ovary cell mutant, characterization, and functional analysis. J. Biol. Chem. 274:12593-604
207. Shimozawa N, Tsukamoto T, Suzuki Y, Orii T, Fujiki Y. 1992. Animal cell mutants represent two complementation groups of peroxisome-defective Zellweger syndrome. J. Clin. Invest. 90:1864-70
208. Shimozawa N, Tsukamoto T, Suzuki Y, Orii T, Shirayoshi Y, et al. 1992. A human gene responsible for Zellweger syndrome that affects peroxisome assembly. Science 255:1132-34
209. Shimozawa N, Imamura A, Zhang Z, Suzuki Y, Orii T, et al. 1999. Defective PEX gene products correlate with the protein import, biochemical abnormalities, and phenotypic heterogeneity in peroxisome biogenesis disorders. J. Med. Genet. 36:779-81
210. Shimozawa N, Suzuki Y, Zhang Z, Imamura A, Toyama R, et al. 1999. Nonsense and temperature-sensitive mutations in PEX13 are the cause of complementation group H of peroxisome biogenesis disorders. Hum. Mol. Genet. 8:1077-83
211. Shimozawa N, Zhang Z, Suzuki Y, Imamura A, Tsukamoto T, et al. 1999. Functional heterogeneity of C-terminal peroxisome targeting signal 1 in PEX5-defective patients. Biochem. Biophys. Res. Comm. 262:504-8
212. Shimozawa N, Suzuki Y, Zhang Z, Imamura A, Ghaedi K, et al. 2000. Identification of PEX3 as the gene mutated in a Zellweger syndrome patient lacking peroxisomal remnant structures. Hum. Mol. Genet. 9:1995-99
213. Shimozawa N, Zhang Z, Imamura A, Suzuki Y, Fujiki Y, et al. 2000. Molecular mechanism of detectable catalase-containing particles, peroxisomes, in fibroblasts from a PEX2-defective patient. Biochem. Biophys. Res. Comm. 268:31-35
214. Shimozawa N, Nagase T, Takemoto Y, Suzuki Y, Fujiki Y, et al. 2002. A novel aberrant splicing mutation of the PEX16 gene in two patients with Zellweger syndrome. Biochem. Biophys. Res. Comm. 292:109-12
215. Slawecki M, Dodt G, Steinberg S, Moser AB, Moser HW, Gould SJ. 1995. Identification of three distinct peroxisomal protein import defects in patients with peroxisome biogenesis disorders. J. Cell Sci. 108:1817-29
216. Smith JJ, Marelli M, Christmas RH, Vizeacoumar FJ, Dilworth DJ, et al. 2002. Transcriptome profiling to identify genes involved in peroxisome assembly and function. J. Cell Biol. 158:259-71
217. Smith TF, Gaitatzes C, Saxena K, Neer EJ. 1999. The WD repeat: A common architecture for diverse functions. Trends Biochem. Sci. 24:181-85
218. Snyder WB, Faber KN, Wenzel TJ, Koller A, Luers GH, et al. 1999. Pex19p interacts with pex3p and pex10p and is essential for peroxisome biogenesis in Pichia pastoris. Mol. Biol. Cell 10:1745-61
219. Snyder WB, Koller A, Choy AJ, Johnson MA, Cregg JM, et al. 1999. Pex17p is required for import of both peroxisome membrane and lumenal proteins and interacts with Pex19p and the peroxisome targeting signal-receptor docking complex in Pichia pastoris. Mol. Biol. Cell 10:4005-19
220. Snyder WB, Koller A, Choy AJ, Subramani S. 2000. The peroxin Pex19p interacts with multiple, integral membrane proteins at the peroxisomal membrane. J. Cell Biol. 149:1171-78
221. Soukupova M, Sprenger C, Gorgas K, Kunau WH, Dodt G. 1999. Identification and characterization of the human peroxin PEX3. Eur. J. Cell Biol. 78:357-74
222. South ST, Gould SJ. 1999. Peroxisome synthesis in the absence of preexisting peroxisomes. J. Cell Biol. 144:255-66
223. South ST, Sacksteder KA, Li X, Liu Y, Santos M, Gould SJ. 2000. Inhibitors of COPI and COPII do not block PEX3-mediated peroxisome synthesis. J. Cell Biol. 149:1345-60
224. Spong AP, Subramani S. 1993. Cloning and characterization of PAS5: A gene required for peroxisome biogenesis in the methylotrophic yeast Pichia pastoris. J. Cell Biol. 123:535-48
225. Spranger JW, Opitz JM, Bidder U. 1971. Heterogeneity of chondrodysplasia punctata. Humangenetik 11:190-212
226. Stein K, Schell-Steven A, Erdmann R, Rottensteiner H. 2002. Interactions of Pex7p and Pex18p/Pex21p with the peroxisomal docking machinery: Implications for the first steps in PTS2 protein import. Mol. Cell Biol. 22:6056-69
227. Stone JA, Castillo M. 1998. MR in a patient with Zellweger syndrome presenting without cortical or myelination abnormalities. Am. J. Neuroradiol. 19: 1378-79
228. Subramani S, Koller A, Snyder WB. 2000. Import of peroxisomal matrix and membrane proteins. Annu. Rev. Biochem. 69:399-118
229. Suzuki Y, Shimozawa N, Yajima S, Tomatsu S, Kondo A, et al. 1994. Novel subtype of peroxisomal acyl-CoA oxidase deficiency and bifunctional enzyme deficiency with detectable enzyme protein: Identification by means of complementation analysis. Am. J. Hum. Genet. 54:36-43
230. Suzuki Y, Shimozawa N, Orii T, Tsukamoto T, Osumi T, et al. 2001. Genetic and molecular bases of peroxisome biogenesis disorders. Genet. Med. 3:372-76
231. Swinkels BW, Gould SJ, Bodnar AG, Rachubinski RA, Subramani S. 1991. A novel, cleavable peroxisomal targeting signal at the amino-terminus of the rat 3-ketoacyl-CoA thiolase. EMBO J. 10: 3255-62
232. Tam YY, Rachubinski RA. 2002. Yarrowia lipolytica cells mutant for the PEX24 gene encoding a peroxisomal membrane peroxin mislocalize peroxisomal proteins and accumulate membrane structures containing both peroxisomal matrix and membrane proteins. Mol. Biol. Cell 13:2681-91
233. Tamura S, Shimozawa N, Suzuki Y, Tsukamoto T, Osumi T, Fujiki Y. 1998. A cytoplasmic AAA family peroxin, Pex1p, interacts with Pex6p. Biochem. Biophys. Res. Comm. 245:883-86
234. Tamura S, Matsumoto N, Imamura A, Shimozawa N, Suzuki Y, et al. 2001. Phenotype-genotype relationships in peroxisome biogenesis disorders of PEX1-defective complementation group 1 are defined by Pex1p-Pex6p interactions. Biochem. J. 357:417-26
235. Tanaka A, Okumoto K, Fujiki Y. 2003. cDNA cloning and characterization of the third isoform of human peroxin Pex11p. Biochem. Biophys. Res. Comm. 300:819-23
236. Terlecky SR, Nuttley WM, McCollum D, Sock E, Subramani S. 1995. The Pichia pastoris peroxisomal protein PAS8p is the receptor for the C-terminal tripeptide peroxisomal targeting signal. EMBO J. 14:3627-34
237. Thai TP, Heid H, Rackwitz HR, Hunziker A, Gorgas K, Just WW. 1997. Ether lipid biosynthesis: Isolation and molecular characterization of human dihydroxyacetonephosphate acyltransferase. FEBS Lett. 420:205-11
238. Titorenko VI, Rachubinski RA. 1998. The endoplasmic reticulum plays an essential role in peroxisome biogenesis. Trends Biochem. Sci. 23:231-33
239. Titorenko VI, Rachubinski RA. 1998. Mutants of the yeast Yarrowia lipolytica defective in protein exit from the endoplasmic reticulum are also defective in peroxisome biogenesis. Mol. Cell Biol. 18:2789-803
240. Titorenko VI, Smith JJ, Szilard RK, Rachubinski RA. 1998. Pex20p of the yeast Yarrowia lipolytica is required for the oligomerization of thiolase in the cytosol and for its targeting to the peroxisome. J. Cell Biol. 142:403-20
241. Titorenko VI, Nicaud J-M, Wang H, Chan HYE, Rachubinski RA. 2002. Acyl-CoA oxidase is imported as a heteropentameric, cofactor-containing complex into peroxisomes of Yarrowia lipolytica. J. Cell Biol. 156:481-94
242. Torvik A, Torp S, Kase BE, Ek J, Skjeldal O, Stokke O. 1988. Infantile Refsum's disease: A generalized peroxisomal disorder. Case report with postmortem examination. J. Neurol. Sci. 85:39-53
243. Ulrich J, Hershkowitz N, Heits P, Sigrist T, Baelocker P. 1978. Adrenoleukodystrophy: Preliminary report of a connatal case, light-and electron microscopical, immunohistochemical and biochemical findings. Acta Neuropathol. (Berl.) 43: 77-83
244. Urquhart AJ, Kennedy D, Gould SJ, Crane DI. 2000. Interaction of Pex5p, the type 1 peroxisome targeting signal receptor, with the peroxisomal membrane proteins Pex14p and Pex13p. J. Biol. Chem. 275:4127-36
245. van den Brink DM, Brites P, Haasjes J, Wierzbicki AS, Mitchell J, et al. 2003. Identification of PEX7 as the second gene involved in Refsum disease. Am. J. Hum. Genet. 72:471-77
246. van der Klei IJ, Hilbrands RE, Kiel JA, Rasmussen SW, Cregg JM, Veenhuis M. 1998. The ubiquitin-conjugating enzyme Pex4p of Hansenula polymorpha is required for efficient functioning of the PTS1 import machinery. EMBO J. 17: 3608-18
247. van der Knaap MS, Valk J. 1991. The MR spectrum of peroxisomal disorders. Neuroradiology 33:30-37
248. van Roermund CW, Tabak HF, van den Berg M, Wanders RJ, Hettema EH. 2000. Pex11p plays a primary role in medium-chain fatty acid oxidation, a process that affects peroxisome number and size in Saccharomyces cerevisiae. J. Cell Biol. 150:489-97
249. van Roermund CW, Drissen R, van den Berg M, Ijlst L, Hettema EH, et al. 2001. Identification of a peroxisomal ATP carrier required for medium-chain fatty acid β-oxidation and normal peroxisome proliferation in Saccharomyces cerevisiae. Mol. Cell Biol. 21:4321-29
250. Vanhorebeek I, Baes M, Declercq PE. 2001. Isoprenoid biosynthesis is not compromised in a Zellweger syndrome mouse model. Biochim. Biophys. Acta 1532:28-36
251. Viola A, Confont-Gouny S, Ranjeva JP, Chabrol B, Raybaud C, et al. 2002. MR imaging and MR spectroscopy in rhizomelic chondrodysplasia punctata. Am. J. Neuroradiol. 23:480-83
252. Voorn-Brouwer T, van der Leij I, Hemrika W, Distel B, Tabak HF. 1993. Sequence of the PAS8 gene, the product of which is essential for biogenesis of peroxisomes in Saccharomyces cerevisiae. Biochim. Biophys. Acta 1216:325-28
253. Voorn-Brouwer T, Kragt A, Tabak HF, Distel B. 2001. Peroxisomal membrane proteins are properly targeted to peroxisomes in the absence of COPI-and COPII-mediated vesicular transport. J. Cell Sci. 114:2199-204
254. Walter C, Gootjes J, Mooijer PA, Portsteffen H, Klein C, et al. 2001. Disorders of peroxisome biogenesis due to mutations in PEX1: Phenotypes and PEX1 protein levels. Am. J. Hum. Genet. 69:35-48
255. Walton PA, Gould SJ, Feramisco JR, Subramani S. 1992. Transport of microinjected proteins into peroxisomes of mammalian cells: Inability of Zellweger cell lines to import proteins with the SKL tripeptide peroxisomal targeting signal. Mol. Cell Biol. 12:531-11
256. Walton PA, Wendland M, Subramani S, Rachubinski RA, Welch WJ. 1994. Involvement of 70 kD heat shock proteins in peroxisomal import. J. Cell Biol. 125:1037-46
257. Walton PA, Hill PE, Subramani S. 1995. Import of stably folded proteins into peroxisomes. Mol. Biol. Cell 6:675-83
258. Wanders RJ, Barth PG, Heymans HSA. 2001. Single peroxisomal enzyme deficiencies. In The Metabolic and Molecular Bases of Inherited Disease, ed. CR Scriver, AL Beaudet, WS Sly, D Valle, pp. 3219-56. New York: McGraw-Hill
259. Wanders RJ, Jakobs C, Skjeldal OH. 2001. Refsum disease. In The Metabolic and Molecular Bases of Inherited Disease, ed. CR Scriver, AL Beaudet, WS Sly, D Valle, pp. 3303-21. New York: McGraw-Hill
260. Wanders RJA, Dekker C, Hovarth VAP, Schutgens RBH, Tager JM, et al. 1994. Human alkyldihydroxyacetonephosphate synthase deficiency: A new peroxisomal disorder. J. Inherit. Metab. Dis. 17:315-18
261. Wanders RJA, Mooijer PAW, Dekker C, Suzuki Y, Shimozawa N. 1999. Disorders of peroxisome biogenesis: Complementation analysis shows genetic heterogeneity with strong overrepresentation of one group (PEX1 deficiency). J. Inherit. Metab. Dis. 22:314-18
262. Wang X, Unruh MJ, Goodman JM. 2001. Discrete targeting signals direct Pmp47 to oleate-induced peroxisomes in Saccharomyces cerevisiae. J. Biol. Chem. 276:10897-905
263. Warren DS, Morrell JC, Moser HW, Valle D, Gould SJ. 1998. Identification of PEX10, the gene defective in complementation group 7 of the peroxisome biogenesis disorders. Am. J. Hum. Genet. 63:347-59
264. Warren DS, Wolfe BD, Gould SJ. 2000. Phenotype-genotype relationships in PEX10-deficient peroxisome biogenesis disorder patients. Hum. Mutat. 15:509-21
265. Waterham HR, de Vries Y, Russel KA, Xie W, Veenhuis M, Cregg JM. 1996. The Pichia pastoris PER6 gene product is a peroxisomal integral membrane essential for peroxisome biogenesis and has sequence similarity to the Zellweger syndrome protein PAF-1. Mol. Cell Biol. 16:2527-36
266. Wei H, Kemp S, McGuinness MC, Moser AB, Smith KD. 2000. Pharmacological induction of peroxisomes in peroxisome biogenesis disorders. Ann. Neurol. 47:286-96
267. Wiebel FF, Kunau W-H. 1992. The Pas2 protein essential for peroxisome biogenesis is related to ubiquitin-conjugating enzymes. Nature 359:73-76
268. Wiemer EAC, Nuttley WM, Bertolaet BL, Li X, Franke U, et al. 1995. Human peroxisomal targeting signal-1 receptor restores peroxisomal protein import in cells from patients with fatal peroxisomal disorders. J. Cell Biol. 130:51-65
269. Williams Dr, Elster AD, Cox TD. 1991. Cranial MR imaging in rhizomelic chondrodysplasia punctata. Am. J. Neuroradiol. 12:363-65
270. Wilson GN, Holmes RG, Custer J, Lipkowitz JL, Stover J, et al. 1986. Zellweger syndrome: Diagnostic assays, syndrome delineation and potential therapy. Am. J. Med. Genet. 24:69-82
271. Yahraus T, Braverman N, Dodt G, Kalish JE, Morrell JC, et al. 1996. The peroxisome biogenesis disorder group 4 gene, PXAAA1, encodes a cytoplasmic ATPase required for stability of the PTS1 receptor. EMBO J. 15:2914-23
272. Yamaguchi S, Iga M, Kimura M, Suzuki Y, Shimozawa N, et al. 2001. Urinary organic acids in peroxisomal disorders: A simple screening method. J. Chromatogr. 758:81-86
273. Yoon Y, Pitts KR, Dahan S, McNiven MA. 1998. A novel dynamin-like protein associates with cytoplasmic vesicles and tubules of the endoplasmic reticulum in mammalian cells. J. Cell Biol. 140:779-93
274. Zhang JW, Lazarow PB. 1995. PEB1 (PAS7) in Saccharomyces cerevisiae encodes a hydrophilic, intra-peroxisomal protein that is a member of the WD repeat family and is essential for the import of thiolase into peroxisomes. J. Cell Biol. 129:65-80
275. Zhang Z, Suzuki Y, Shimozawa N, Fukuda S, Imamura A, et al. 1999. Genomic structure and identification of 11 novel mutations of the PEX6 (peroxisome assembly factor-2) gene in patients with peroxisome biogenesis disorders. Hum. Mutat. 14:487-96
276. Zomer AWM, van der Burg B, Jansen GA, Wanders RJ, Poll-The BT, van der Saag PT. 2000. Pristanic acid and phytanic acid: Naturally occurring ligands for the nuclear receptor peroxisome proliferator-activated receptor a. J. Lipid Res. 41:1801-7